Clinical Trials on T Cell Immunodeficiency Primary
Total 7644 results
-
National Cancer Centre, SingaporeCompletedPeripheral T-cell LymphomaSingapore
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownPeripheral T-cell LymphomaChina
-
M.D. Anderson Cancer CenterOrtho Biotech, Inc.Completed
-
Mingzhi ZhangUnknownPeripheral T-cell LymphomaChina
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
CelgeneCompleted
-
Sun Yat-sen UniversityUnknownPeripheral T-cell LymphomaChina
-
Northwestern UniversityCompleted
-
University of BolognaTerminatedPeripheral T-cell LymphomaItaly
-
King Chulalongkorn Memorial HospitalBayerCompleted
-
The Lymphoma Academic Research OrganisationInnate PharmaRecruitingPeripheral T Cell Lymphoma | Relapse/RecurrenceFrance, Spain, Belgium, Germany
-
Hunan Cancer HospitalRecruitingChemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic DisorderChina
-
The University of Hong KongUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin T-cell LymphomaHong Kong
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital and other collaboratorsRecruitingInduction Chemotherapy | Acute T-Lymphocytic Leukemia | T-cell Lymphoblastic Lymphoma Leukemia | T-cell/Myeloid Mixed Phenotype Acute LeukemiaChina
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityCompletedRadiotherapy | Sintilimab | Anlotinib | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Early Stage | Peg-aspargase | Phase Two | OpenChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapse/Refratory Peripheral T Cell LymphomaChina
-
University of MiamiNational Cancer Institute (NCI)TerminatedLymphoma | Precancerous/Nonmalignant ConditionUnited States
-
Ruijin HospitalNot yet recruiting
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Institute of Hematology & Blood Diseases HospitalRecruitingPeripheral T Cell Lymphoma | Epigenetic RepressionChina
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... and other collaboratorsRecruiting
-
CStone PharmaceuticalsCompletedExtranodal Natural Killer/T-Cell LymphomaChina
-
CelgeneActive, not recruiting
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMycosis Fungoides | Sezary Syndrome | Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Peking Union Medical College HospitalUnknownDiffuse Large B Cell Lymphoma | Peripheral T-Cell Lymphoma | Lymphoma,Non-Hodgkin
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; The Affiliated Hospital Of Guizhou... and other collaboratorsRecruitingHigh-Risk Cancer | Early-stage | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
GenmabCompletedCutaneous T-Cell LymphomaUnited Kingdom, Germany, United States, Sweden
-
Sorrento Therapeutics, Inc.RecruitingMycosis FungoidesUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Completed
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLCWithdrawn
-
Fudan UniversityRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Rong TaoRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
German CLL Study GroupGenzyme, a Sanofi Company; University of CologneCompletedT-cell-prolymphocytic LeukemiaGermany
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); NYU Langone Health and other collaboratorsCompleted
-
Mingzhi ZhangUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Sun Yat-sen UniversityFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsUnknownHigh Risk | T-cell Lymphoma Adults | Previously UntreatedChina
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Sun Yat-sen UniversityRecruitingExtranodal Natural Killer T Cell LymphomaChina
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedPeripheral T Cell Lymphoma | Treatment-naïveChina
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States